These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 9563708

  • 21. The Sero-epidemiology of Coxiella burnetii in Humans and Cattle, Western Kenya: Evidence from a Cross-Sectional Study.
    Wardrop NA, Thomas LF, Cook EA, de Glanville WA, Atkinson PM, Wamae CN, Fèvre EM.
    PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005032. PubMed ID: 27716804
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Estimated prevalence of chronic Q fever among Coxiella burnetii seropositive patients with an abdominal aortic/iliac aneurysm or aorto-iliac reconstruction after a large Dutch Q fever outbreak.
    Hagenaars JC, Wever PC, van Petersen AS, Lestrade PJ, de Jager-Leclercq MG, Hermans MH, Moll FL, Koning OH, Renders NH.
    J Infect; 2014 Aug; 69(2):154-60. PubMed ID: 24647145
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Seroprevalence of infection by Coxiella burnetii in Canary Islands (Spain).
    Bolaños M, Santana OE, Angel-Moreno A, Pérez-Arellano JL, Limiñana JM, Serra-Majem L, Martín-Sánchez AM.
    Eur J Epidemiol; 2003 Aug; 18(3):259-62. PubMed ID: 12800952
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Seroprevalence and risk factors of Coxiella burnetii infection among high-risk population in center of Iran, a neglected health problem.
    Nokhodian Z, Ataei B, Moradi A, Yaran M, Hoseini SG, Feizi A, Sherkat R.
    Acta Trop; 2017 May; 169():107-111. PubMed ID: 28167053
    [Abstract] [Full Text] [Related]

  • 30. The seroprevalence of Coxiella burnetii in Erzincan, Turkey: Identification of the risk factors and their relationship with geographical features.
    Cikman A, Aydin M, Gulhan B, Karakecili F, Ozcicek A, Kesik OA, Parlak M, Ozcelik F, Gültepe B.
    J Vector Borne Dis; 2017 May; 54(2):157-163. PubMed ID: 28748837
    [Abstract] [Full Text] [Related]

  • 31. Febrile patients admitted to remote hospitals in Northeastern Kenya: seroprevalence, risk factors and a clinical prediction tool for Q-Fever.
    Njeru J, Henning K, Pletz MW, Heller R, Forstner C, Kariuki S, Fèvre EM, Neubauer H.
    BMC Infect Dis; 2016 Jun 03; 16():244. PubMed ID: 27260261
    [Abstract] [Full Text] [Related]

  • 32. The First Serological Study of Q Fever in Humans in Lebanon.
    Dabaja MF, Greco G, Villari S, Bayan A, Vesco G, Gargano V, Arnone M, Hneino M, Lelli R, Ezzedine M, Berry A, Mortada H, Tempesta M, Mortada M.
    Vector Borne Zoonotic Dis; 2018 Mar 03; 18(3):138-143. PubMed ID: 29336692
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Prevalence of antibodies to Coxiella burnetii among farming population in eastern Poland.
    Cisak E, Chmielewska-Badora J, Mackiewicz B, Dutkiewicz J.
    Ann Agric Environ Med; 2003 Mar 03; 10(2):265-7. PubMed ID: 14677923
    [Abstract] [Full Text] [Related]

  • 35. [Investigation of Coxiella burnetii and Brucella seropositivities in patients presenting with acute fever].
    Günal O, Barut S, Ayan M, Kılıç S, Duygu F.
    Mikrobiyol Bul; 2013 Apr 03; 47(2):265-72. PubMed ID: 23621726
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.